Science for a Safer World

LGC is a leading global life science tools company, providing mission-critical components and solutions into high-growth application areas across the human healthcare and applied market segments.

Our 180 years of scientific heritage, combined with a track record of innovation and value-enhancing acquisitions, has enabled us to build our product portfolio and expertise, and develop deep relationships with customers, industry partners and the global scientific community.

Viral epidemics and pandemics

Outcomes

We help assay developers and clinical labs respond to outbreaks like coronavirus, Ebola and Zika. Our AccuPlex recombinant viral materials are safe to handle and non-infectious, while resembling complex clinical virus targets, making them a crucial tool in developing effective solutions to fight infectious disease epidemics like COVID-19.

LGC's response to the COVID-19 Pandemic

Innovation in nucleic acid therapies

Outcomes

Through our nucleic acid chemistry capabilities, we enable healthcare professionals to develop new therapies, which transform the quality of life for patients. Our oligo components, probes and primers enable detection and development of vaccines for illnesses like COVID-19.

Improving farming productivity

Outcomes

We partner with agricultural biotechnology companies to solve the productivity challenge that sits at the heart of the global food supply problem. Our range of products and services help accelerate breeding decisions in an efficient and cost-effective manner, such as identifying new plant varieties.

Latest news

LGC acquires PolyDesign

National Measurement Laboratory at LGC supports the UK global leadership in ensuring accurate diagnostics for future pandemics.

LGC acquires Virusys Corporation.